Skip to content
Triangle logo TriangleGet started
← Langerhans Cell Histiocytosis

HEALTH PROFESSIONAL · SOURCE READING

Targeted therapy

Source: Langerhans Cell Histiocytosis Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: January 6, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Childhood LCH / Recurrent, Refractory, or Progressive Childhood LCH / Treatment of recurrent, refractory, or progressive high-risk disease: multisystem LCH

Continue within this section

MAPK inhibitors →Tyrosine kinase inhibitors →

Preserved source evidence · Not medical advice

Targeted therapy · Langerhans Cell Histiocytosis | Triangle